The use of HEPES-buffer in the production of gallium-68 radiopharmaceuticals – time to reconsider strict pharmacopoeial limits?

Springer Science and Business Media LLC - Tập 6 - Trang 1-4 - 2021
Jannie le Roux1, Janke Kleynhans2, Sietske Rubow2
1NuMeRI Node for Infection Imaging, Central Analytical Facilities, Stellenbosch University, Stellenbosch, South Africa
2Nuclear Medicine Division, Stellenbosch University, Stellenbosch, South Africa

Tóm tắt

HEPES (4-(2-hydroxyethyl) piperazine-1-ethanesulfonic acid) is a buffer that is used in the radiolabelling of gallium-68 compounds. The beneficial effects of HEPES on molar activity in bioconjugates have been well described. Current strict regulations on the HEPES content in radiopharmaceuticals limit its use when intended for parenteral administration. This short communication summarizes data from the literature on the toxicity of HEPES in dogs after intravenous infusion and the subsequent use in humans. We also highlight the use of HEPES in an FDA labelled intravenous drug formulation. Regulatory institutions may consider this data to review current strict limits.

Tài liệu tham khảo

Antunes IF, Franssen GM, Zijlma R, Laverman P, Boersma HH, Elsinga PH. New sensitive method for HEPES quantification in 68Ga-radiopharmaceuticals. EJNMMI Radiopharm. Chem. 2020;5(1):12. Baker DE, Levien TL. Irinotecan liposome injection. Hosp Pharm. 2017;52(2):144–150. https://doi.org/10.1310/hpj5202-144. Bauwens M, Chekol R, Vanbilloen H, Bormans G, Verbruggen A. Optimal buffer choice of the radiosynthesis of 68Ga-Dotatoc for clinical application. Nucl Med Commun. 2010;31(8):753–758. https://doi.org/10.1097/MNM.0b013e32833acb99. Eppard E, Wuttke M, Nicodemus PL, Rosch F. Ethanol-based post-processing of generator-derived 68Ga toward kit-type preparation of 68Ga-radiopharmaceuticals. J Nucl Med. 2014;55(6):1023–1028. https://doi.org/10.2967/jnumed.113.133041. Good NE, Winget GD, Winter W, Connolly TN, Izawa S, Singh RMM. Hydrogen ion buffers for biological research. Biochem Int. 1966;5(2):467–477. Available from:. https://doi.org/10.1021/bi00866a011. Merrimack. ONIVYDE Prescribing Information; 2015. p. 1–18. Pfaff S, Nehring T, Pichler V, Cardinale J, Mitterhauser M, Hacker M, et al. Development and evaluation of a rapid analysis for HEPES determination in 68Ga-radiotracers. EJNMMI Res. 2018;8:95. European Pharmacopoeia. Gallium (68Ga) edotreotide injection; 2017. Sasson R, Vaknin D, Bross A, Lavie E. Determination of HEPES in 68Ga-labeled peptide solutions. J Radioanal Nucl Chem. 2010;283(3):753–756. https://doi.org/10.1007/s10967-010-0449-0. Theodore TR, Van Zandt RL, Carpenter RH. Pilot ascending dose tolerance study of parenterally administered 4-(2 hydroxyethyl)-1-piperazine ethane sulfonic acid (TVZ-7) in dogs. Cancer Biother Radiopharm. 1997a;12(5):345–349. https://doi.org/10.1089/cbr.1997.12.345. Theodore TR, Van Zandt RL, Carpenter RH. Preliminary evaluation of a fixed dose of zwitterionic piperazine (TVZ- 7) in clinical cancer. Cancer Biother Radiopharm. 1997b;12(5):351–353. https://doi.org/10.1089/cbr.1997.12.351. Velikyan I, Beyer GJ, Långstrom B, Chemistry O. Microwave-supported preparation of 68Ga bioconjugates with high specific radioactivity. Bioconjug Chem. 2004;15:554–560.